<DOC>
	<DOCNO>NCT02741687</DOCNO>
	<brief_summary>The purpose study compare sitagliptin placebo prevention high glucose general surgery .</brief_summary>
	<brief_title>Sitagliptin Non-Diabetic Patients Undergoing General Surgery</brief_title>
	<detailed_description>Approximately 30-40 % hospitalized patient develop stress hyperglycemia ( high glucose response surgery illness ) . High glucose link increase risk hospital complication include wound infection , kidney failure death . Patients high glucose treated insulin give arm vein frequent insulin injection skin . Sitagliptin oral medication approve Food Drug Administration ( FDA ) treat patient diabetes . The aim study determine whether treatment sitagliptin daily prevent development stress hyperglycemia postoperative period non-diabetic patient undergo general surgery .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Undergoing noncardiac surgery No previous history diabetes hyperglycemia Fasting blood glucose level &lt; 126 mg/dl Blood glucose &lt; 126mg/dl time randomization ( could occur time day ) History hyperglycemia ( blood glucose equal 126 mg/dl HbA1C great 6.5 % ) previous treatment oral antidiabetic agent insulin Patients undergoing cardiac surgery Patients anticipated require ICU care follow surgery Severely impaired renal function ( GFR &lt; 30 ml/min ) clinically significant hepatic failure Moribund patient imminent risk death ( brain death cardiac standstill ) Patients gastrointestinal obstruction adynamic illeus expect require gastrointestinal suction Patients clinically relevant pancreatic gallbladder disease Treatment oral ( &gt; 5 mg/day ) injectable corticosteroid Mental condition render subject unable understand nature , scope , possible consequence study Pregnancy breastfeed time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>stress hyperglycemia</keyword>
	<keyword>blood glucose</keyword>
</DOC>